Compare ORMP & FINW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ORMP | FINW |
|---|---|---|
| Founded | 2002 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.3M | 194.4M |
| IPO Year | 2010 | 2021 |
| Metric | ORMP | FINW |
|---|---|---|
| Price | $4.11 | $14.05 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 516.0K | 41.3K |
| Earning Date | 05-14-2026 | 04-30-2026 |
| Dividend Yield | ★ 6.51% | N/A |
| EPS Growth | ★ 412.50 | 21.51 |
| EPS | ★ 0.91 | 0.20 |
| Revenue | ★ $2,000,000.00 | N/A |
| Revenue This Year | N/A | $160.48 |
| Revenue Next Year | N/A | $35.27 |
| P/E Ratio | ★ $4.45 | $69.60 |
| Revenue Growth | ★ 49.25 | N/A |
| 52 Week Low | $1.98 | $12.82 |
| 52 Week High | $5.19 | $22.49 |
| Indicator | ORMP | FINW |
|---|---|---|
| Relative Strength Index (RSI) | 47.66 | 47.53 |
| Support Level | $3.69 | $13.72 |
| Resistance Level | $4.22 | $15.17 |
| Average True Range (ATR) | 0.28 | 0.61 |
| MACD | -0.06 | -0.04 |
| Stochastic Oscillator | 16.67 | 19.02 |
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and commercial customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.